Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_assertion type Assertion NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_head.
- NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_assertion wasGeneratedBy ECO_0000203 NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_provenance.
- NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_assertion wasDerivedFrom befree-20150227 NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_provenance.
- NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_assertion SIO_000772 12618518 NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_provenance.
- NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_assertion evidence source_evidence_literature NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_provenance.
- NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_assertion description "[We have shown that cytotoxic T lymphocytes specific for PR1, an HLA-A2-restricted nonopeptide derived from proteinase 3, kill leukemia cells and may contribute to the elimination of chronic myelogenous leukemia (CML) after treatment with IFN or allogeneic bone marrow transplant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477705.RAcBz15tblYg1Gk2ZvJ0z2hbCMY-GhP_38BFAD0iJCSQ8130_provenance.